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Obstacles in initiating a new research project – Reﬂection on medical
research in UK1. Main text
Medical research planning and initiation is becoming increas-
ingly difﬁcult and frustrating in the current climate in the UK.
Many new researchers have little knowledge of how to initiate
a research project and are often unaware of the challenges, time
constraints and red tape they encounter in this process.
Initiation of new research project has the following
components.
1. Selection of an appropriate research topic.
2. Literature search.
3. Writing a research protocol.
4. Discussing the protocol with research team and concerned
departments.
5. Ethical approval.
6. MHRA approval (if study involves any medication).
7. Trust Research & Development (R&D) approval.
Patient recruitment cannot be commenced prior to completion
of the above mentioned components. Only the ﬁrst three compo-
nents in this list are under direct control of the researcher. Difﬁcul-
ties start arising from this point onwards.
Once written, the research protocol has to be discussed within
the research team and with all concerned departments. This
involves meetings, telephone conversations and prolonged email
correspondence. The whole process can be extremely arduous
and time consuming. Getting everyone around the table at one
time can be extremely difﬁcult due to the number of people
involved, their schedules and commitments.
Ethics review committees are gatekeepers to human research
enterprise. Their main aim is to ensure that research respects the
dignity, rights, safety and well being of individual research
participants. With the establishment of National Research Ethics
Service (NRES), all applications are submitted via online ethics
application form using Integrated Research Applications System
(IRAS). This form is very extensive; comprising detailed back-
ground, justiﬁcation for research, methods, investigations, proce-
dures, safe guards, timing, trial monitoring and dissemination.
Once completed and submitted, it generates a unique ID number
which is printed on each page of the application form. This
precludes any further amendments to the application even if
they are minor spelling errors or missed words. Any amendment
results in resubmission and generation of a new ID number. A
printout of the submitted form has to be signed by the principal1743-9191/$ – see front matter  2010 Surgical Associates Ltd. Published by Elsevier Lt
doi:10.1016/j.ijsu.2010.08.001investigator, supervisor and R&D manager. In addition, if the
study involves exposure to ionising radiations (X-rays, nuclear
medicine tests) a signature is required from the Lead Medical
Physicist who should be an ARSAC (Administration of Radioactive
Substances Advisory Committee) certiﬁcate holder. A signed hard
copy is then sent to the ofﬁce of local research ethics committee
(LREC).
Following submission, the wait starts for ethics committee
meeting, for consideration of application. Although the ethics
committees meet regularly, it can take a few weeks to a few
months for an application to be considered, depending upon
how many applications have been received by the committee.
Attendance at the meeting is optional for the researcher and has
its own pros and cons. The major beneﬁt in attending is the chance
to explain the project face to face and answer the queries raised as
a result saving precious time. The disadvantage is that the meeting
can be quite intense, and new researchers can be quite intimi-
dated with the examination like atmosphere created by the pres-
ence of around 15 people in the room asking critical and grilling
questions. The ethics committee decision is usually notiﬁed to
the researcher in aweek’s time. Results from the ethics committee
can be favourable, provisional or unfavourable. A favourable
opinion means that the study has been approved; provisional
means that part of the application has to be re-submitted in accor-
dance with the changes suggested by the committee; and unfav-
ourable means that major concerns have been raised by the
committee and the project needs a complete redesign and
resubmission.
MHRA (Medicines and Healthcare products Regulatory Agency)
approval is required if the study involves the use of any medicinal
product. All such studies are classiﬁed as Trial of an investigational
medicinal product (TIMP).
Even after a favourable opinion by the ethics committee and
MHRA approval, R&D approval is required. It only issues ﬁnal
approval letter once service manager approval is obtained from
all departments involved, irrespective of whether it is routine or
research work. For example; Pathology service manger approval
will be required if a study patient has to undergo blood tests
even if that is a part of routine care. Thus, approval may be required
from 4 to 6 departments in even the simplest of studies.
Althoughmost of the stepsmentioned above are initiated simul-
taneously, time taken for their completion is highly variable and
can range from 4 months to a year depending upon circumstances.
As most of the research jobs offered to clinicians are usually for two
years, this delay in initiation or recruitment has a direct effect ond. All rights reserved.
Letter to the Editor / International Journal of Surgery 8 (2010) 656–657 657a researchers’ moral, project timescale, thesis submission and
quality control. Simpliﬁcation of these processes is required to
ensure growth of quality research in UK.
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